Material Agreements

INVO Fertility, Inc. amended Amendment to the Warrant Agent Agreement with Transfer Online, Inc. (effective 2024-04-17).

“On April 17, 2024, the Company and the Warrant Agent entered into an Amendment to the Warrant Agent Agreement (the “Amendment”) to confirm that the Company may adjust the exercise price of the of the Warrants to provide an exercise price per share that is lower than the then-current exercise price of the Warrants.”

Progressive Care Inc. entered into Merger Agreement and Plan of Reorganization with NextPlat Corp (effective 2024-04-12).

“On April 12, 2024, Progressive Care Inc., a Delaware corporation (the “ Company ”) entered into a Merger Agreement and Plan of Reorganization (the “ Merger Agreement ”) with NextPlat Corp”

Research Solutions, Inc. entered into PNC Loan Agreement with PNC Bank, National Association valued at secured revolving line of credit of $500,000 (effective 2024-04-15).

“On April 15, 2024, Research Solutions, Inc. (the “ Company ”) and Reprints Desk, Inc., a wholly owned subsidiary of the Company (collectively and individually, the “ Borrower ”) entered into a Loan Agreement (the “ PNC Loan Agreement ”) with PNC Bank, National Association (“ PNC ”), as lender.”

TransMontaigne Partners LLC amended Amendment No. 2 with Barclays Bank PLC, as administrative agent and collateral agent, and the lenders party thereto valued at $150 million (effective 2024-04-15).

“TransMontaigne Partners LLC (the “Company”), as parent guarantor, and TransMontaigne Operating Company L.P., a Delaware limited partnership and wholly owned subsidiary of the Company (“OpCo”), entered into an Amendment No. 2 (the “Amendment”) to its existing Credit Agreement dated as of November 17, 2021 among the Company, OpCo, Barclays Bank PLC, as administrative agent and collateral agent, and the lenders party thereto, which provides for, among other things, the incurrence of a new tranche of term loans under the credit facility in an aggregate principal amount of $150 million (the “Incremental Term Loan Facility”).”

Vanda Pharmaceuticals Inc. entered into Rights Agreement with Equiniti Trust Company, LLC (effective 2024-04-17).

“The complete terms of the Rights are set forth in a Rights Agreement (the “Rights Agreement”), dated as of April 17, 2024, between the Company and Equiniti Trust Company, LLC, a limited trust company organized under the laws of the State of New York, as rights agent.”

ARES CAPITAL CORP amended BNP Funding Facility with BNP valued at Seventh Amendment to the Revolving Credit and Security Agreement; adjusted interest rate margin from (effective 2024-04-12).

“On April 12, 2024, the Company and ARCC FB Funding LLC, a wholly owned subsidiary of the Company (“AFB LLC”), amended the document governing AFB LLC’s revolving funding facility (the “BNP Funding Facility”) by entering into a Seventh Amendment to the Revolving Credit and Security Agreement (the “BNP Amendment”).”

ARES CAPITAL CORP amended A&R Credit Facility with JPMorgan Chase Bank, N.A. valued at Amended and restated senior secured credit facility; total commitment reduced from approximately $4. (effective 2024-04-12).

“On April 12, 2024, Ares Capital Corporation (the “Company”) amended and restated its senior secured credit facility, among the Company, the lenders party thereto, and JPMorgan Chase Bank, N.A., as the administrative agent (as amended and restated, the “A&R Credit Facility”).”

BATTALION OIL CORP amended Fourth Amendment with Fury Resources, Inc. and San Jacinto Merger Sub, Inc. (effective 2024-04-16).

“On April 16, 2024, Battalion Oil Corporation, a Delaware corporation (the " Company " or " we "), Fury Resources, Inc., a Delaware corporation (" Parent "), and San Jacinto Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (" Merger Sub "), entered into a Fourth Amendment (the " Fourth Amendment ") to the Agreement and Plan of Merger, dated as of December 14, 2023 (the " Merger Agreement "), by and among the Company, Parent and Merger Sub”

NETLIST INC amended Fourth Amendment with Equiniti Trust Company, LLC (effective 2024-04-17).

“fourth amendment (the “Fourth Amendment”) to the Rights Agreement. The Fourth Amendment appoints Equiniti Trust Company,”

ABVC BIOPHARMA, INC. entered into Oncox Agreement with OncoX BioPharma, Inc. valued at $6,250,000 (or 1,250,000 Oncox shares valued at $5 per share) (effective 2024-04-16).

“On April 16, 2024, the Company entered into a definitive agreement with OncoX BioPharma, Inc., a private company registered in the British Virgin Islands (" Oncox "), pursuant to which the Company will grant Oncox an exclusive right to develop and commercialize ABVC's single-herb botanical drug extract from the dry fruit body of Maitake Mushroom (Grifola Frondosa) for treatment of Non-Small Cell Lung Cancer (the “ Licensed Products ”), within North America for 20 years (the “ Oncox Agreement ”).”

EXACT SCIENCES CORP entered into Fifth Supplemental Indenture with U.S. Bank Trust Company, National Association valued at $620,709,000 aggregate principal amount of 1.75% Convertible Senior Notes due 2031 (effective 2024-04-17).

“completed the closing of the transactions contemplated by those exchange and purchase agreements dated April 10, 2024 (the “Agreements”) entered into with certain holders (the “Holders”) of the Company’s 0.375% Convertible Senior Notes due 2028 (the “2028 Notes”). Pursuant to the terms of the Agreements, the Company issued to the Holders $620,709,000 aggregate principal amount of 1.75% Convertible Senior Notes due 2031 (the “2031 Notes”) in exchange for $359,662,000 aggregate principal amount of the Holders’ 2028 Notes and $266,750,000 in cash. The 2031 Notes were issued pursuant to an indenture dated as of January 17, 2018 (the “Base Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”), as supplemented by the fifth supplemental indenture dated as of April 17, 2024 (the “Supplemental Indenture” and together with the Base Indenture, the “Indenture”).”

CORCEPT THERAPEUTICS INC entered into Sublease with Zuora, Inc. valued at base rent of an average of $1.4 million annually and Shared Amenities Space base rent of an average (effective 2024-04-12).

“On April 12, 2024, Corcept Therapeutics Incorporated (“Corcept”) entered into a sublease (the “Sublease”) with Zuora, Inc. for a portion of the premises located at 101 Redwood Shores Parkway, Redwood City, California 94065 (the “Building”).”

INOVIO PHARMACEUTICALS, INC. entered into Underwriting Agreement with Oppenheimer & Co. Inc. and Citizens JMP Securities, LLC, as representatives of the several underwriters named therein valued at approximately $33.2 million (effective 2024-04-15).

“On April 15, 2024, Inovio Pharmaceuticals, Inc. (the “ Company ”) entered into an underwriting agreement (the “ Underwriting Agreement ”) with Oppenheimer & Co. Inc. and Citizens JMP Securities, LLC, as representatives of the several underwriters named therein (collectively, the “ Underwriters ”), relating to the issuance and sale by the Company in an underwritten registered direct offering (the “ Offering ”) of 2,536,258 shares (the “ Shares ”) of the Company’s common stock, par value $0.001 per share (the “ Common Stock ”), at a price of $7.693 per share and pre-funded warrants to purchase up to 2,135,477 shares of Common Stock (the “ Pre-Funded Warrants ”) at a price of $7.692 per Pre-Funded Warrant, which represents the per share price for the Shares less the $0.001 per share exercise price for each Pre-Funded Warrant.”

MFA FINANCIAL, INC. entered into Third Supplemental Indenture with Wilmington Trust, National Association (effective 2024-04-17).

“The Notes were issued under the indenture, dated June 3, 2019 (the “Base Indenture”), as supplemented by the third supplemental indenture, dated April 17, 2024 (the “Third Supplemental Indenture,” and together with the Base Indenture, the “Indenture”), by and between the Company and Wilmington Trust, National Association, as trustee.”

MFA FINANCIAL, INC. entered into Underwriting Agreement with Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, UBS Securities LLC, Wells Fargo Securities, LLC and Piper Sandler & Co. valued at $75 million (effective 2024-04-15).

“The Notes were sold pursuant to an underwriting agreement (the “Underwriting Agreement”), dated as of April 15, 2024, by and among the Company and Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, UBS Securities LLC, Wells Fargo Securities, LLC and Piper Sandler & Co. as representatives of the several underwriters named therein (collectively, the “Underwriters”), whereby the Company agreed to sell to the Underwriters and the Underwriters agreed to purchase from the Company, subject to and upon the terms and conditions set forth in the Underwriting Agreement, the Notes.”

NRG ENERGY, INC. amended Eighth Amendment to the Second Amended and Restated Credit Agreement with Citicorp North America, Inc. valued at $875.0 million term loan B facility (effective 2024-04-16).

“On April 16, 2024, NRG Energy, Inc. (“ NRG ”), as borrower, and certain subsidiaries of NRG, as guarantors, entered into the Eighth Amendment to the Second Amended and Restated Credit Agreement (the “ Eighth Amendment ”) with, among others, Citicorp North America, Inc., as administrative agent and as collateral agent (the “ Agent ”), and certain financial institutions, as lenders, which amended NRG’s Second Amended and Restated Credit Agreement, dated as of June 30, 2016 (the “ Credit Agreement ”), in order to (i) establish a new term loan B facility with borrowings of $875.0 million in aggregate principal amount (the “ Term Loan Facility ” and the loans thereunder, the “ Term Loans ”) and (ii) make certain other modifications to the Credit Agreement as set forth therein.”

Resonate Blends, Inc. amended Amendment (effective 2024-03-18).

“On March 18, 2024, the signatories to the Exchange Agreement (defined in Item 2. Completion of Acquisition or Disposition of Assets ) executed and amendment (the “ Amendment ”), pursuant to which certain prospective parties to the Exchange Agreement were removed as such.”

Resonate Blends, Inc. entered into Conveyance Agreement with Geoffrey Selzer (effective 2024-03-14).

“On March 14, 2024, Resonate Blends, Inc., a Nevada corporation (the “ Company ”), entered into an Agreement of Conveyance, Transfer and Assignment of Subsidiary (the “ Conveyance Agreement ”) with two of its then-wholly-owned subsidiaries, Resonate Blends, LLC, a California limited liability company, and Entourage Labs, LLC, a California limited liability company (collectively, Resonate Blends, LLC and Entourage Labs, LLC are referred to as the “ Subsidiary ”), and one of its former directors, Geoffrey Selzer (“ Selzer ”).”

ACADIA REALTY TRUST amended Third Amended and Restated Credit Agreement with Bank of America, N.A., as administrative agent, Wells Fargo Bank, National Association, Truist Bank, and PNC Bank, National Association, as syndication agents, BofA Securities, Inc. and Wells Fargo Securities, LLC, as joint bookrunners, and BofA Securities, Inc., Wells Fargo Securities, LLC, Truist (effective 2024-04-15).

“On April 15, 2024, Acadia Realty Limited Partnership, a Delaware limited partnership (the “Operating Partnership”), and its general partner, Acadia Realty Trust, a Maryland real estate investment trust (the “Company”), entered into a Third Amended and Restated Credit Agreement (the “Third Amended and Restated Credit Facility”) with Bank of America, N.A., as administrative agent, Wells Fargo Bank, National Association, Truist Bank, and PNC Bank, National Association, as syndication agents, BofA Securities, Inc. and Wells Fargo Securities, LLC, as joint bookrunners, and BofA Securities, Inc., Wells Fargo Securities, LLC, Truist Securities, Inc. and PNC Capital Markets LLC, as joint lead arrangers, and the lenders and letter of credit issuers party thereto.”

AGCO CORP /DE amended Amended and Restated Letter Agreement with Tractors and Farm Equipment Limited (effective 2024-04-15).

“On April 15, 2024, AGCO Corporation (“AGCO”) and Tractors and Farm Equipment Limited (“TAFE”) amended the Amended and Restated Letter Agreement dated as of April 24, 2019, between AGCO and TAFE to extend the expiration date from April 24, 2024, to April 24, 2025.”

RespireRx Pharmaceuticals Inc. entered into Purchase Agreement with Dariusz Nasiek and Sara Nasiek, JTTEN valued at $100,000.00 (effective 2024-04-10).

“On April 10, 2024, the RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”) entered into a Demand Promissory Note and Warrant Agreement (“Purchase Agreement”)”

Lifevantage Corp entered into Loan Agreement with Bank of America, N.A. valued at $5,000,000 (effective 2024-04-12).

“On April 12, 2024, LifeVantage Corporation (the “Company”) entered into a Loan Agreement (the “Loan Agreement”) with Bank of America, N.A., as Lender (the “Lender”).”

Oil-Dri Corp of America entered into Seventh Amendment to Credit Agreement with BMO Bank N.A. (effective 2024-04-16).

“7 to the BMO Credit Agreement In connection with the Transaction, on April 16, 2024, the Company entered into the Seventh Amendment to Credit Agreement (the “Seventh Amendment”), which amends that certain Credit Agreement, dated as of January 27, 2006, as amended (the “Credit Agreement”), among BMO Bank N.A.”

Oil-Dri Corp of America entered into Purchase Agreement with Ultra Pet, LLC, Ultra Pet Company, Inc., and certain equityholders of Seller valued at approximately $46 million (effective 2024-04-16).

“Stock Purchase Agreement On April 16, 2024, Oil-Dri Corporation of America, a Delaware corporation (the “Company”), entered into a Stock Purchase Agreement (the “Purchase Agreement”) with Ultra Pet, LLC, a Delaware limited liability company (“Seller”), Ultra Pet Company, Inc., a Delaware corporation (“Ultra Pet”), and certain equityholders of Seller set forth on the signature page thereto (“Seller’s Equityholders”), pursuant to which the Company has agreed to purchase all of the issued and outstanding shares of capital stock of Ultra Pet (the “Shares”) from Seller (the “Transaction”).”

PAYCHEX INC amended 2017 Credit Facility Amendment with a syndicate of lenders for which JPMorgan Chase Bank, N.A. acts as Administrative Agent valued at $750.0 million (effective 2024-04-12).

“On April 12, 2024, PoNY and the Parent entered into an amendment (the “2017 Credit Facility Amendment”) to the $750.0 million, five-year, unsecured, revolving credit facility established on August 17, 2017 (the “2017 Credit Facility”)”

PAYCHEX INC amended 2019 Credit Facility Amendment with a syndicate of lenders for which JPMorgan Chase Bank, N.A. acts as Administrative Agent valued at $1.0 billion (effective 2024-04-12).

“On April 12, 2024, Paychex of New York LLC, a Delaware limited liability company (“PoNY”) and Paychex, Inc., a Delaware corporation (the “Parent”), entered into an amendment (the “2019 Credit Facility Amendment”) to the $1.0 billion, five-year, unsecured, revolving credit facility established on July 31, 2019 (the “2019 Credit Facility”)”

INTERNATIONAL PAPER CO /NEW/ entered into Co-operation Agreement with DS Smith Plc (effective 2024-04-16).

“nnouncement (the “ Rule 2.7 Announcement ”), pursuant to Rule 2.7 of the United Kingdom City Code on Takeovers and Mergers (the “ Code ”) disclosing the terms of a recommended offer by the Company to acquire the entire issued and to be issued share capital of DS Smith Plc, a public limited company incorporated in England and Wales (“ DS Smith ”), in an all-stock transaction (the “ Business Combination ”).”

Bunge Global SA amended $1.1 Billion 364-Day Revolving Credit Agreement with Coöperatieve Rabobank U.A., New York Branch, as administrative agent, and certain other lenders valued at $1.1 billion (effective 2024-04-12).

“On April 12, 2024, Bunge Limited Finance Corp. (“ BLFC ”), a wholly owned subsidiary of Bunge Global SA (“ Bunge ”), amended and restated its existing $1.1 billion 364-day Revolving Credit Agreement (the “ $1.1 Billion 364-Day Revolving Credit Agreement ”) with Coöperatieve Rabobank U.A., New York Branch, as administrative agent, and certain other lenders (the “ Lenders ”), to extend the maturity date from June 19, 2024 to April 11, 2025.”

BranchOut Food Inc. entered into Subscription Agreement with investors that purchased Notes and Warrants from the Company on January 10, 2024 valued at $400,000 (effective 2024-01-10).

“The First Amendment incorporates and amends certain provisions of the Subscription Agreement, dated January 10, 2024 (the “Subscription Agreement”), previously entered into by the Company and investors that purchased Notes and Warrants from the Company on January 10, 2024 (the “January Investors”).”

BranchOut Food Inc. entered into First Amendment to Subscription Agreement with a group of seven investors valued at $225,000 (effective 2024-04-16).

“On April 16, 2024, BranchOut Food Inc. (the “Company”) completed the sale of $225,000 of Senior Secured Promissory Notes (“Notes”), and Warrants (“Warrants”) to purchase an aggregate of 56,250 shares of the Company’s common stock, to a group of seven investors (the “Investors”), pursuant to a First Amendment to Subscription Agreement between the Company and the Investors dated as of April 16, 2024 (the “First Amendment”).”

Bridger Aerospace Group Holdings, Inc. entered into Purchase Agreements with certain accredited investors valued at aggregate gross proceeds ... approximately $9.8 million (effective 2024-04-15).

“On April 15, 2024, Bridger Aerospace Group Holdings, Inc. (the “Company”) entered into securities purchase agreements (each, a “Purchase Agreement” and, collectively, the “Purchase Agreements”) with certain accredited investors (the “Purchasers”), pursuant to which the Company agreed to sell and issue to the Purchasers, severally, an aggregate of 2,183,366 shares (the “Shares”) of common stock, $0.0001 par value per share, of the Company (the “Common Stock”), in a registered direct offering (the “Registered Offering”).”

Abpro Holdings, Inc. entered into Subscription Agreement with Polar Multi-Strategy Master Fund valued at up to $360,000 (effective 2024-04-10).

“On April 10, 2024, Atlantic Coastal Acquisition Corp. II (“ACAB”), Polar Multi-Strategy Master Fund (the “Investor”), and Atlantic Coastal Acquisition Management II LLC, ACAB’s sponsor (the “Sponsor”) entered into a subscription agreement (the “Subscription Agreement”) pursuant to which the Investor agreed to provide a capital contribution to the Sponsor in an aggregate amount of up to $360,000 (the “Capital Contribution”) in exchange for 1 share of ACAB’s Series A common stock (“ACAB common stock”) held by the Sponsor for each $1 invested by the Investor as of the closing of ACAB’s proposed business combination (the “De-SPAC Closing”), provided that the obligation to make capital contributions will terminate on September 19, 2024.”

Kairous Acquisition Corp. Ltd entered into Note with Kairous Asia Limited valued at aggregate principal amount of $50,000 (effective 2024-04-12).

“On April 12, 2024, Kairous Acquisition Corp. Limited (the “Company” or “Kairous”) issued an unsecured promissory note in the aggregate principal amount of $50,000 (the “Note”) to Kairous Asia Limited, the Company’s initial public offering sponsor (“Sponsor”)”

Innovative Eyewear Inc entered into At the Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $1,120,446 (effective 2024-04-15).

“On April 15, 2024, Innovative Eyewear, Inc., a Florida corporation (the “ Company ”), entered into an At the Market Offering Agreement (the “ Agreement ”) with H.C. Wainwright & Co., LLC, as sales agent (“ HCW ”), to create an at-the-market equity program.”

American Outdoor Brands, Inc. amended Amended and Restatement Trademark License Agreement with Smith & Wesson Inc. valued at 5% royalty on net sales, minimum $150,000 per quarter, five-year initial term from May 1, 2024 (effective 2024-04-11).

“On April 11, 2024, AOB Products Company, a wholly owned subsidiary of American Outdoor Brands, Inc. ("we" or "us") entered into an Amended and Restatement Trademark License Agreement (the "Trademark License Agreement"), with Smith & Wesson Inc. ("SW"), pursuant to which the parties agreed to amend and restate the Trademark License Agreement, dated August 24, 2020 (the "Original Agreement").”

Cullinan Therapeutics, Inc. entered into Stock Purchase Agreement with certain institutional accredited investors valued at $280M gross proceeds for sale of 14,421,070 shares at $19.00/share and 315,790 pre-funded warrants a (effective 2024-04-15).

“On April 15, 2024, Cullinan Therapeutics, Inc. (formerly known as Cullinan Oncology, Inc.) (the “ Company ”) entered into a Stock Purchase Agreement (the “ Purchase Agreement ”) for a private placement (the “ Private Placement ”) with certain institutional accredited investors named therein (each, a “ Purchaser ” and collectively, the “ Purchasers ”).”

Nexentis Technologies Inc. entered into Note with YA II PN, Ltd. valued at $1,500,000 promissory note (effective 2024-04-04).

“On April 4, 2024, N2OFF, Inc., a Nevada corporation (the “Company”), sold a $1,500,000 promissory note (the “Note”) to YA II PN, Ltd. (the “Investor”) in exchange for proceeds of $1,455,000, reflecting an original issue discount of 3% to face value .”

IMAC Holdings, Inc. entered into Securities Purchase Agreement with accredited investors valued at aggregate cash proceeds ... of $900,000 (effective 2024-04-10).

“the Company entered into a securities purchase agreement (the “Securities Purchase Agreement”) with accredited investors (the “Investors”), pursuant to which the Company agreed to issue and sell, and the Investors agreed to purchase, 1,276 shares of Series C-2 convertible preferred stock”

CAMPBELL'S Co terminated Old Credit Agreement with JPMorgan Chase Bank, N.A. valued at terminated in connection with the entry into the Credit Agreement described in Item 1.01 above (effective 2024-04-16).

“On April 16, 2024, the Company terminated its Five-Year Credit Agreement, dated September 27, 2021, among the Company, certain of its subsidiaries from time to time party thereto, JPMorgan, as administrative agent, and the other lenders named therein, which established an unsecured, senior revolving credit facility in the aggregate principal amount equal to $1.85 billion (as amended by that certain Amendment No. 1, dated as of April 4, 2023, the "Old Credit Agreement").”

CAMPBELL'S Co entered into Five-Year Credit Agreement with JPMorgan Chase Bank, N.A. valued at unsecured, senior revolving credit facility, aggregate principal amount equal to $1.85 billion, matu (effective 2024-04-16).

“On April 16, 2024, Campbell Soup Company (the "Company") entered into a Five-Year Credit Agreement with JPMorgan Chase Bank, N.A. ("JPMorgan"), as administrative agent, and the other lenders named therein (the "Credit Agreement").”

Barnes & Noble Education, Inc. entered into Commitment Letter for New ABL Facility with the lenders under its existing asset-based revolving credit facility valued at $325 million aggregate committed principal amount (effective 2024-04-16).

“On April 16, 2024, the Company entered into a commitment letter with the lenders under its existing asset-based revolving credit facility (the “Existing ABL Facility”) to provide for a new four-year asset-based credit facility in an aggregate committed principal amount of $325 million (the “New ABL Facility”), which New ABL Facility will replace the Existing ABL Facility.”

Barnes & Noble Education, Inc. entered into Twelfth Amendment to Credit Agreement with lenders under its existing asset-based revolving credit facility valued at Amendment to Existing ABL Facility revising milestones to align with Purchase Agreement transactions (effective 2024-04-16).

“On April 16, 2024, the Company amended its Existing ABL Facility to, among other things, revise certain milestones related to the previously-disclosed liquidity and refinancing contingency plans to align such milestones with the Transactions contemplated by the Purchase Agreement (the “Twelfth Amendment to Credit Agreement”),”

Barnes & Noble Education, Inc. entered into Purchase Agreement with Toro 18 Holdings LLC, Selz Family 2011 Trust, Outerbridge Capital Management, LLC, Vital Fundco, LLC, TopLids LendCo, LLC valued at Up to $140 million in aggregate value, including $45 million rights offering, $45 million standby pu (effective 2024-04-16).

“On April 16, 2024, Barnes & Noble Education, Inc. (the “Company,” “we,” “our” or “us”) entered into a standby, securities purchase and debt conversion agreement (the “Purchase Agreement”) with Toro 18 Holdings LLC (“Immersion”), Selz Family 2011 Trust (“Selz”), Outerbridge Capital Management, LLC (“Outerbridge”, and together with Immersion and Selz, the “Standby Purchasers”), Vital Fundco, LLC (“Vital”) and TopLids LendCo, LLC (“TopLids”, together with the Standby Purchasers and Vital, the “Purchasers”).”

RHYTHM PHARMACEUTICALS, INC. entered into Investment Agreement with certain affiliates of Perceptive Advisors LLC and certain other investors valued at $150,000,000 (effective 2024-04-01).

“the Company entered into an Investment Agreement (the “Investment Agreement”) with certain affiliates of Perceptive Advisors LLC (“Perceptive”) and certain other investors (each, an “Investor” and collectively, the “Investors”), relating to the issuance and sale of 150,000 shares of a new series of the Company’s Series A Convertible Preferred Stock, par value $0.001 per share, titled the “Series A Convertible Preferred Stock” (the “Convertible Preferred Stock”), for an aggregate purchase price of $150,000,000, or $1,000 per share”

Sigyn Therapeutics, Inc. amended Debentures with Brio Capital Master Fund Ltd. and Osher Capital Partners, LLC valued at $110,000 and $275,000 (effective 2024-04-10).

“Brio and Osher agreed to amend an additional $110,000 and $275,000, respectively, of Debentures to extend the maturity dates of such Debentures to March 31, 2025 in return for an increase in principal amount of such Debentures to $125,000 and $316,350”

Viridian Therapeutics, Inc.\DE amended Fourth Amendment to Lease Agreement with Watch City Ventures MT, LLC valued at base rent $38,232.33 per month for first year, increasing 2% annually; tenant improvement allowance (effective 2024-04-08).

“On April 10, 2024, Viridian Therapeutics, Inc. (the “Company”) entered into a Fourth Amendment to Lease Agreement (the “Amendment”), effective April 8, 2024, with Watch City Ventures MT, LLC (“Landlord"), to amend that certain Lease, dated January 13, 2020, by and between the Company and Landlord (the “Lease"), as amended on July 6, 2021, April 13, 2022 and July 29, 2022, for the lease of an aggregate of 10,956 square feet of rentable area of the building located at 221 Crescent Street, Waltham, Massachusetts (the “Original Premises"), which serves as the Company’s headquarters.”

Arq, Inc. amended Seventh Amendment to Tax Asset Protection Plan with Computershare Trust Company, N.A. valued at amends the definition of Final Expiration Date; extends until December 31, 2025 or December 31, 2024 (effective 2024-04-15).

“On April 15, 2024, Arq, Inc. (the "Company"), a Delaware corporation, entered into the Seventh Amendment to Tax Asset Protection Plan (the "Seventh Amendment") between the Company and Computershare Trust Company, N.A. (the "Rights Agent") that amends the Tax Asset Protection Plan dated May 5, 2017, as amended (the "TAPP") between the Company and the Rights Agent.”

Akebia Therapeutics, Inc. amended Amendment #2 to the Supply Agreement with STA Pharmaceutical Hong Kong Limited (effective 2024-04-15).

“(the “Company”) entered into a Supply Agreement with STA Pharmaceutical Hong Kong Limited, a Hong Kong corporation (“STA”), as amended on April 15, 2021 (as amended, the “Supply Agreement”), under which STA manufactures vadadustat drug substance (“Product”) for the Company’s commercial purposes.”

PetVivo Holdings, Inc. entered into Promissory Note with A.L. Sarroff Fund, LLC valued at $300,000 (effective 2024-04-10).

“s of April 10, 2024, A.L. Sarroff Fund, LLC (the “Lender”), a greater than 10% shareholder in PetVivo Holdings, Inc. (the “Company”) entered into a promissory note dated April 10, 2024 (the “Promissory Note”), in the amount”

AMERICAN BATTERY MATERIALS, INC. amended Promissory Note Amendment Agreement with one investor valued at principal amount of $25,000 with accrued interest of $2,971 (effective 2024-03-29).

“C. Amendment of Promissory Note : The Company entered into a Promissory Note Amendment Agreement with one investor holding a promissory note in the principal amount of $25,000 with accrued interest of $2,971.”